From January 1, 2022 to March 31, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on February 25, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.84 USD | -0.06% | -0.37% | -21.19% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.19% | 79.55B | |
+43.64% | 754B | |
+39.42% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.92% | 217B | |
-2.62% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Tranche Update on Gilead Sciences, Inc.'s Equity Buyback Plan announced on February 25, 2020.